MassMutual Private Wealth & Trust’s Terns Pharmaceuticals TERN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-264	Closed	-$13.9K	–	2492
2026 Q1	$13.9K	Buy	264 +24	+10%	+$986	﹤0.01%	1242
2025 Q4	$9.7K	Buy	240 +74	+45%	+$1.71K	﹤0.01%	1402
2025 Q3	$1.25K	Buy	+166	New	+$1.06K	﹤0.01%	2107

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MassMutual Private Wealth & Trust's TERN Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 264 shares — an estimated $13.9K sold.

MassMutual Private Wealth & Trust first reported a position in TERN in Q3 2025 and held it in 3 quarters. The position peaked at $13.9K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

MassMutual Private Wealth & Trust reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 264 Terns Pharmaceuticals shares in Q2 2026, an estimated $13.9K.
MassMutual Private Wealth & Trust first reported a position in Terns Pharmaceuticals in Q3 2025 and held it in 3 quarters.
MassMutual Private Wealth & Trust's Terns Pharmaceuticals position peaked at $13.9K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.